Mark A. Muesing

4.5k total citations · 2 hit papers
36 papers, 3.8k citations indexed

About

Mark A. Muesing is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mark A. Muesing has authored 36 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 22 papers in Infectious Diseases and 22 papers in Molecular Biology. Recurrent topics in Mark A. Muesing's work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (22 papers) and Biochemical and Molecular Research (8 papers). Mark A. Muesing is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (22 papers) and Biochemical and Molecular Research (8 papers). Mark A. Muesing collaborates with scholars based in United States, Japan and Sweden. Mark A. Muesing's co-authors include M. WISKERCHEN, Lubbertus C. F. Mulder, Douglas H. Smith, Cirilo D. Cabradilla, Laurence A. Lasky, Charles V. Benton, Daniel J. Capon, Barry Polisky, Gianni Cesareni and Paul D. Bieniasz and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark A. Muesing

34 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein

1987 612 citations Mark A. Muesing Cell profile →
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

1985 598 citations Mark A. Muesing et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Muesing United States	24	2.0k	1.9k	1.3k	725	623	36	3.8k
Bahige M. Baroudy United States	37	1.8k 0.9×	1.2k 0.6×	1.7k 1.4×	758 1.0×	1.1k 1.7×	65	4.3k
Martin L. Bryant United States	28	1.0k 0.5×	1.0k 0.5×	1.0k 0.8×	596 0.8×	1.3k 2.0×	48	3.2k
Mamuka Kvaratskhelia United States	41	2.3k 1.1×	3.1k 1.6×	2.0k 1.6×	330 0.5×	423 0.7×	115	4.6k
Jonathan Leis United States	46	3.2k 1.6×	3.8k 2.0×	2.4k 1.9×	747 1.0×	1.2k 2.0×	108	6.8k
Brigitte Rosenwirth Austria	30	899 0.4×	1.1k 0.6×	781 0.6×	603 0.8×	633 1.0×	93	2.7k
Anna Marie Skalka United States	44	2.7k 1.3×	3.7k 1.9×	2.7k 2.1×	333 0.5×	732 1.2×	103	5.6k
Kirsten M. Stray United States	18	1.6k 0.8×	1.2k 0.7×	1.3k 1.1×	380 0.5×	623 1.0×	25	3.1k
Mark Krystal United States	45	981 0.5×	2.7k 1.4×	1.9k 1.5×	1.0k 1.4×	3.3k 5.3×	134	6.5k
Roger G. Ptak United States	33	1.3k 0.6×	1.3k 0.7×	1.1k 0.9×	390 0.5×	735 1.2×	93	3.1k
Judith G. Levin United States	44	3.1k 1.5×	3.2k 1.7×	2.1k 1.7×	528 0.7×	872 1.4×	83	5.1k

Countries citing papers authored by Mark A. Muesing

Since Specialization

Citations

This map shows the geographic impact of Mark A. Muesing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Muesing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Muesing more than expected).

Fields of papers citing papers by Mark A. Muesing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Muesing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Muesing. The network helps show where Mark A. Muesing may publish in the future.

Co-authorship network of co-authors of Mark A. Muesing

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Muesing. A scholar is included among the top collaborators of Mark A. Muesing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Muesing. Mark A. Muesing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Yang, Erica Y. Jacobs, Todd M. Greco, et al.. (2016). HIV–host interactome revealed directly from infected cells. Nature Microbiology. 1(7). 16068–16068. 40 indexed citations

Trinité, Benjamin, Chi Ngai Chan, Caroline Sunyong Lee, et al.. (2014). Suppression of Foxo1 Activity and Down-Modulation of CD62L (L-Selectin) in HIV-1 Infected Resting CD4 T Cells. PLoS ONE. 9(10). e110719–e110719. 35 indexed citations

Deverasetty, Sandeep, et al.. (2011). HIVToolbox, an Integrated Web Application for Investigating HIV. PLoS ONE. 6(5). e20122–e20122. 15 indexed citations

Luo, Yang & Mark A. Muesing. (2010). Prospective Strategies for Targeting HIV-1 Integrase Function. Future Medicinal Chemistry. 2(7). 1055–1060. 7 indexed citations

Low, Andrea, Nicole Prada, Florin Vaida, et al.. (2009). Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors. Antimicrobial Agents and Chemotherapy. 53(10). 4275–4282. 70 indexed citations

Berthoux, Lionel, Sarah Sebastian, Mark A. Muesing, & Jeremy Luban. (2007). The role of lysine 186 in HIV-1 integrase multimerization. Virology. 364(1). 227–236. 31 indexed citations

Tateishi, Satoshi, et al.. (2006). Effect of DNA Repair Protein Rad18 on Viral Infection. PLoS Pathogens. 2(5). e40–e40. 32 indexed citations

Muesing, Mark A., et al.. (2006). Characterization of HIV-1 integrase N-terminal mutant viruses. Virology. 360(1). 129–135. 16 indexed citations

Mulder, Lubbertus C. F., Lisa A. Chakrabarti, & Mark A. Muesing. (2002). Interaction of HIV-1 Integrase with DNA Repair Protein hRad18. Journal of Biological Chemistry. 277(30). 27489–27493. 63 indexed citations

10.

Cowan, Simone, et al.. (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proceedings of the National Academy of Sciences. 99(18). 11914–11919. 237 indexed citations

11.

Mulder, Lubbertus C. F. & Mark A. Muesing. (2000). Degradation of HIV-1 Integrase by the N-end Rule Pathway. Journal of Biological Chemistry. 275(38). 29749–29753. 83 indexed citations

12.

Gordon, Cynthia J., Mark A. Muesing, Amanda E. I. Proudfoot, et al.. (1999). Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion. Journal of Virology. 73(1). 684–694. 113 indexed citations

13.

Staschke, Kirk A., et al.. (1998). Inhibition of Influenza Virus Hemagglutinin-Mediated Membrane Fusion by a Compound Related to Podocarpic Acid. Virology. 248(2). 264–274. 49 indexed citations

14.

Jungheim, Louis N., et al.. (1996). ChemInform Abstract: Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded D‐Amino Acids as P2/P3 Ligands.. ChemInform. 27(18).

15.

Kaldor, Stephen W., Krzysztof Appelt, James E. Fritz, et al.. (1995). A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 5(7). 715–720. 7 indexed citations

16.

MUNROE, J. E., Timothy A. Shepherd, Louis N. Jungheim, et al.. (1995). Potent, orally bioavailable HIV-1 protease inhibitors containing noncoded D-amino acids. Bioorganic & Medicinal Chemistry Letters. 5(23). 2897–2902. 10 indexed citations

17.

Hornback, William J., J. E. MUNROE, Timothy A. Shepherd, et al.. (1995). Synthesis and pharmacokinetics of potent carbamate HIV-1 protease inhibitors containing novel high affinity hydroxyethylamine isosteres. Bioorganic & Medicinal Chemistry Letters. 5(23). 2891–2896.

18.

Muesing, Mark A.. (1987). Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell. 48(4). 691–701. 612 indexed citations breakdown →

19.

Cesareni, Gianni, Mark A. Muesing, & Barry Polisky. (1982). Control of ColE1 DNA replication: the rop gene product negatively affects transcription from the replication primer promoter.. Proceedings of the National Academy of Sciences. 79(20). 6313–6317. 168 indexed citations

20.

Muesing, Mark A.. (1981). A single base-pair alteration is responsible for the DNA overproduction phenotype of a plasmid copy-number mutant. Cell. 24(1). 235–242. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact